Viracta Therapeutics, Inc. (topcash18.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Viracta Therapeutics. Track Viracta Therapeutics Inc (VIRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and. View the latest VIRX share price or buy & sell Viracta Therapeutics stock on NASDAQ using Lightyear. Viracta Therapeutics Inc is a precision oncology. On average, Wall Street analysts predict that Viracta Therapeutics's share price could reach $ by Aug 16, The average Viracta Therapeutics stock price. Get the latest Viracta Therapeutics Inc (VIRX) real-time quote, historical performance, charts, and other financial information to help you make more.
Stock/Option, Shares, Shares Change, Price, Cost, Final Share. Anna Hannah. Chief Executive Officer. 01/01/ Buy. Option. K. 95%. $ $, Viracta Therapeutics, Inc. (VIRX) completes Stage 2 enrollment in NAVAL-1 trial of Nana-val for EBV+ lymphoma, expects topline results in Q2 Strengthened. VIRX | Complete Viracta Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. VIRX - Viracta Therapeutics Inc - Stock screener for investors and traders, financial visualizations. Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact. View Viracta Therapeutics, Inc. VIRX stock quote prices, financial information, real-time forecasts, and company news from CNN. Select the date below to view the historical closing price for that particular day. The closing price is not indicative of future price performance. Viracta Therapeutics Inc (VIRX) USD · Add to watchlist · This stock can be held in a · Stocks and Shares ISA Lifetime ISA SIPP Fund and Share Account. View Viracta Therapeutics (VIRX) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers. On Wednesday morning 08/28/ the Viracta Therapeutics Inc Registered Shs share started trading at the price of $ Compared to the closing price on.
Price Target. The average one-year price target for Viracta Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. Stock Information ; Open. $ ; Change. $ (%) ; Day's Range. $ - $ ; Week Range. $ - $ ; Volume. K. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Viracta Therapeutics (VIRX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Discover real-time Viracta Therapeutics, Inc. Common Stock (VIRX) stock prices, quotes, historical data, news, and Insights for informed trading and. Stock price history for Viracta Therapeutics (VIRX). Highest end of day price: $9, USD on Lowest end of day price: $ USD on We are a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide. Viracta Therapeutics Inc. ; Volume, K ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Viracta Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next.
Yes, Indians can invest in the Viracta Therapeutics Inc (VIRX) from India. With INDmoney, you can buy Viracta Therapeutics Inc at 0 brokerage. The step-by-step. Viracta Therapeutics Inc VIRX:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/01/23 · 52 Week. See the latest Viracta Therapeutics Inc stock price (VIRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Stock analysis for Viracta Therapeutics Inc (VIRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company. View live Viracta Therapeutics, Inc. chart to track its stock's price action. Find market predictions, VIRX financials and market news.
Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you up. Convert Viracta Therapeutics Inc stocks or. Viracta Therapeutics, Inc. (US:VIRX) has 53 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission . PROFILE (VIRX). Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-. Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated.
Lowest Tax Bracket 2021 | Money Books To Read